Icon
+91 94997 68112
Login Register

Xyzal - (5 mg; Tablet, Oral)

Levocetirizine Dihydrochloride Sanofi
5 mg; Tablet, Oral
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
 None
More Than 5
More Than 5
Used to relieve allergy symptoms such as watery eyes, runny nose, itching eyes/nose, and sneezing
Yes
******* *** *** ***** ** **** **** ** **** ***** *** ****** *** ******** ** ***** **, ****. ******* *** ************ ********* ** ***. ***** *** ******, **** (****) & ****** **** ***** * **** ** **** **** ****** ** ******* *** **** ************ **** ** ***.
Xyzal Patent 1
******* ****** *******
*** ****** *******
****** **** *********
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
******* ****** *** \ ** *** **, **** ******* ******** ******** ** *** **, ****
*** ****** ** \ ** ***, **** ******* ******** ******** ** **** ****
****** ** \ ** *** **, **** **** ********* **** *** ** ******
  1. *** **, **** : ******* ****** ******** *** *** ***** *** **** ** ****** *********** ****** ** '***
  2. *** **, **** : *** *** **** ******* ****** **** *** **** ** ****** ** ******** ***** ** ********.
  3. *** **, **** : *** *** **** ******* ****** **** *** **** ** ****** ** ******** ***** *** ******* ******** ** ***** ******** ******* ********.********* *** ********** ********* ** ******** ***** ** ********.
  4. *** **, **** : *** ****** ******** *** *** ***** *** **** ** ****** *********** ****** ** '***
  5. *** **, **** : ****** ******** *** *** ***** *** **** ** ****** *********** ****** ** '***
  6. ***, **** : *** *** **** *** ****** **** *** **** ** ****** ** ******** ***** *** ******* ******** ** ***** ******** ******* ********.
  7. *** **, **** : ********** ********* **** ******* ******
  8. *** **, **** : *** *** **** ****** **** *** **** ** ****** ** ******** ***** *** ******* ***** ** ***** ********.
  9. *** **, **** : **** (****) ******** *** *** ***** *** **** ** ****** *********** ****** ** '***
  10. *** **, **** : *** *** **** **** (****) **** *** **** ** ****** ** ******** ***** ** ******* ******** ** ***** ********
  11. *** *, **** : ********** ********* **** *** ******
  12. *** *, **** : *** *** **** **** (****) **** *** **** ** ****** ** ******** ***** ** *** ******
  13. *** *, **** : ******* ****** ******** *** *** ***** *** **** ** ****** **** ***** ******** ***** **** ********, *********** ****** '***
  14. *** **, **** : *** *** **** ******* ****** **** *** **** ** ****** **** *** ***** ******** **** ******** ** ******** ***** *** ******* ***** ** ***** ********.
  15. ***, **** : ****** **** **** *** **** ** & *********** ** ** ***** *** *****. *** *** ***** *** ******** **** ********* **********.
  16. ***, **** : *** & ******** ***** * ****** ** ******** ** ****** **** **** ****** & ** ******* ****** '* ***** *** *****. ** *** **** **** ****** ***** * ****** ** ******* *** ****** ********** *** **** ** ******* ****** ************.
  17. *** **, **** : *** ***** * ******* ******** ********** *** *** *** ** ***** ********* ** ***** ******** *** *** **** **** ******** ******** ******** **** ****** ** ****** *** ***** '* ********** *** ******** ******** (***) *** ******** ******** ******** (***).
  18. *** **, **** : ******* ******** ******** & ******* *** *******.
  19. *** **, **** : *** '* ** *** ****** *** ** *** **** *** ** ***** '* & ******** ******** ******** (********** ***** ***** *** *****) & ******** *** *******.
  20. *** **, **** : ********** ********* **** ****

Xyzal - (2.5MG/5ML (0.5mg/ ml); Solution, Oral)

Levocetirizine Dihydrochloride Sanofi
2.5MG/5ML (0.5mg/ ml); Solution, Oral
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
 None
Less Than 5
Less Than 5
Used to relieve allergy symptoms such as watery eyes, runny nose, itching eyes/nose, and sneezing
Yes
******* *** *** ***** ** **** **** ** **** ****** ******** ** **** **, **** *** *** ************ ********* ** ***. ** ****** **** **** ******* ******* ** ******** ****. ******* *** *** **** ******* * ********** **** *** ****** ******* ** *****. **** * ********** *** ** ******** *** *** **** ******** ***. ** ** ********* ** **** **** * ********* **** ******** ******** *** ***** ****** **** ***** *** ***** *** ********* *** ******* ****** *** ****. ***** *** ******* ** ******* ******** *** ******** ***.
Xyzal Patent 1
******* ****** *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
******* ****** *** \ *** *** **,**** ******* ******** ******** ** *** ****
  1. *** *, **** : ******* ****** ******** *** *** ***** *** **** ** ****** *********** ****** ** '***.
  2. *** **, **** : *** *** **** ******* ****** **** *** **** ** ****** ** ******** ***** *** ******* ******** ** ***** ********.
  3. . : ***** ******* ** ******** ** *** ****, *** ** ******** **** *** ********** ** *******

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.